Session Information
2008 Midyear Clinical Meeting
Click here to go to the previous page
Making Sense of Oral Antiplatelet Therapy in Coronary Artery Disease
Track:
Educational Sessions
Program Code: 259-L01
Date: Wednesday, December 10, 2008
Time: 8:00 AM to 9:50 AM EST
Location:
S230G
MEETING PLANNING ASSOCIATE:
Ms. Naomi Schultheis, MEd, Director, Standards Development and Training, American Society of Health-System Pharmacists
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
LEARNER OUTCOMES:
- Describe potential mechanisms of contributors to variability in response to oral antiplatelet agents.
- Discuss emerging oral antiplatelet agents.
- Provide a recommendation and justification for duration of dual oral antiplatelet therapy.
- Provide a recommendation and justification for the appropriate dose and timing of oral antiplatelet therapy in acute coronary syndromes.
- Summarize the current data and guidelines regarding use of oral antiplatelet therapy for secondary prevention of coronary artery disease.